HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasushi Adachi Selected Research

Insulin-Like Peptides

11/2021Insulin-Like Growth Factor 2 and Incidence of Liver Cancer in a Nested Case-Control Study.
1/2020Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study.
12/2019Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors.
11/2016Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.
3/2013Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
2/2012Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
8/2011The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status.
7/2011Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
12/2010A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers.
2/2010Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasushi Adachi Research Topics

Disease

68Neoplasms (Cancer)
09/2022 - 08/2002
18Carcinoma (Carcinomatosis)
12/2021 - 02/2003
15Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 10/2002
10Adenocarcinoma
02/2021 - 09/2007
10Stomach Neoplasms (Stomach Cancer)
02/2021 - 03/2004
9Carcinogenesis
08/2022 - 01/2004
9Neoplasm Metastasis (Metastasis)
08/2022 - 02/2003
8Colonic Neoplasms (Colon Cancer)
09/2014 - 10/2002
8Adenoma (Adenomas)
08/2014 - 12/2004
7Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2017 - 08/2009
6Hepatocellular Carcinoma (Hepatoma)
02/2021 - 06/2008
6Lung Neoplasms (Lung Cancer)
11/2019 - 01/2003
6Esophageal Squamous Cell Carcinoma
02/2014 - 05/2007
6Ischemia
01/2012 - 04/2004
5Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 10/2003
5Graft vs Host Disease (Graft-Versus-Host Disease)
05/2011 - 09/2005
4Colitis
11/2019 - 07/2009
3Esophageal Neoplasms (Esophageal Cancer)
05/2017 - 11/2005
3Microsatellite Instability
01/2015 - 06/2012
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2014 - 07/2009
2Renal Insufficiency (Renal Failure)
08/2022 - 03/2005
2Liver Diseases (Liver Disease)
01/2022 - 01/2020
2Liver Neoplasms (Liver Cancer)
11/2021 - 11/2016
2Infections
10/2016 - 07/2012
2Fibrosis (Cirrhosis)
12/2015 - 11/2009
2Inflammation (Inflammations)
12/2015 - 01/2003
2Pathologic Constriction (Stenosis)
02/2015 - 11/2008
2Hemorrhage
01/2013 - 11/2008
2Infarction (Infarctions)
01/2013 - 05/2009
2Biliary Tract Neoplasms (Biliary Tract Cancer)
02/2012 - 08/2009
2Body Weight (Weight, Body)
08/2011 - 07/2011
2Leukemia
05/2011 - 07/2006
2Atherosclerosis
05/2011 - 01/2011
2Autoimmune Diseases (Autoimmune Disease)
11/2009 - 03/2005

Drug/Important Bio-Agent (IBA)

18Insulin-Like PeptidesIBA
11/2021 - 10/2002
13IGF Type 1 Receptor (IGF 1 Receptor)IBA
02/2014 - 10/2002
10Messenger RNA (mRNA)IBA
09/2011 - 11/2002
10Matrix Metalloproteinases (MMPs)IBA
08/2009 - 01/2003
9Proteins (Proteins, Gene)FDA Link
11/2019 - 05/2002
7Insulin-Like Growth Factor I (IGF-1)IBA
02/2012 - 10/2002
7Matrix Metalloproteinase 7 (Matrilysin)IBA
08/2009 - 01/2003
6DNA (Deoxyribonucleic Acid)IBA
10/2019 - 05/2002
6Calcibiotic Root Canal SealerIBA
12/2014 - 06/2007
5MicroRNAs (MicroRNA)IBA
09/2022 - 06/2012
5Insulin (Novolin)FDA Link
01/2020 - 08/2011
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2019 - 03/2005
5Pharmaceutical PreparationsIBA
11/2016 - 03/2005
5Formaldehyde (Formol)FDA Link
08/2014 - 01/2003
5Small Interfering RNA (siRNA)IBA
02/2010 - 03/2007
5beta CateninIBA
11/2009 - 09/2006
5RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2008 - 08/2003
4CytokinesIBA
11/2019 - 06/2006
4ParaffinIBA
08/2014 - 01/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011 - 04/2004
3Therapeutic UsesIBA
09/2022 - 07/2009
3ORALIT (ORS)IBA
11/2021 - 11/2016
3ErbB Receptors (EGF Receptor)IBA
01/2017 - 12/2012
3Biomarkers (Surrogate Marker)IBA
03/2015 - 06/2012
3DecitabineFDA Link
03/2013 - 11/2005
3Insulin-Like Growth Factor II (Somatomedin A)IBA
02/2012 - 12/2004
3LigandsIBA
07/2011 - 03/2007
3Growth Factor ReceptorsIBA
12/2010 - 11/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2007 - 12/2004
3Macrophage Colony-Stimulating FactorIBA
06/2006 - 03/2005
3Complementary DNA (cDNA)IBA
12/2004 - 05/2002
2Cisplatin (Platino)FDA LinkGeneric
08/2022 - 03/2005
2BilirubinIBA
01/2022 - 01/2016
2CateninsIBA
12/2021 - 06/2011
2Glucose (Dextrose)FDA LinkGeneric
11/2021 - 08/2011
2Triglycerides (Triacylglycerol)IBA
11/2021 - 01/2015
2Interleukin-6 (Interleukin 6)IBA
11/2019 - 01/2013
2Anaplastic Lymphoma KinaseIBA
07/2019 - 08/2017
2Keratins (Keratin)IBA
07/2019 - 01/2018
2Tyrosine Kinase InhibitorsIBA
01/2019 - 06/2008
2Monoclonal AntibodiesIBA
01/2017 - 08/2011
2human ERBB2 proteinIBA
01/2016 - 12/2012
2Aminolevulinic Acid (Levulan)FDA Link
09/2014 - 02/2011
21-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2014 - 02/2011
2Codon (Codons)IBA
08/2014 - 01/2007
2CarcinogensIBA
04/2014 - 06/2010
2Dextran SulfateIBA
04/2014 - 02/2014
2trichostatin A (A 300)IBA
03/2013 - 06/2011
2MethyltransferasesIBA
03/2013 - 06/2007
2RNA (Ribonucleic Acid)IBA
12/2012 - 03/2007
2Somatomedin Receptors (Somatomedin Receptor)IBA
02/2012 - 10/2002
2Neuroprotective AgentsIBA
01/2012 - 06/2007
2Histone Deacetylase InhibitorsIBA
06/2011 - 05/2008
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2011 - 05/2009
2Tumor Viral Antigens (Large T Antigen)IBA
11/2009 - 05/2008
2NVP-AEW541IBA
08/2009 - 06/2008
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2009 - 08/2007
2EnzymesIBA
09/2006 - 11/2002

Therapy/Procedure

21Therapeutics
09/2022 - 10/2002
10Drug Therapy (Chemotherapy)
08/2022 - 10/2002
8Transplantation
01/2015 - 02/2002
7Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2015 - 03/2005
2Radiotherapy
08/2022 - 01/2019
2Nephrectomy
01/2021 - 02/2020
2Photochemotherapy (Photodynamic Therapy)
09/2014 - 02/2011
2Microbubbles
06/2006 - 11/2005